Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04814342 · ClinicalTrials.gov registry record

Accuracy of Pulse Oximeters With Profound Hypoxia During Motion

A clinical trial of Hypoxia, sponsored by Nihon Kohden.

Completed
Registry status
5
Enrollment target
1
Study location

NCT04814342: Completed study of Hypoxia, sponsored by Nihon Kohden.

NCT04814342 is a study of Hypoxia that has completed, run by Nihon Kohden. The registered enrollment target is 5 participants, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04814342, a study of Hypoxia, has completed, sponsored by Nihon Kohden.

COMPLETED
Registry status
5 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients during controlled motion.

Primary Outcome

Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter (SpO2i) to that obtained from a blood sample (SRi) and calculating the arithmetic root mean square (Arms) error value as follows: Arms =Square root (sum of n samples of ((SpO2i - SRi) squared) / n)

Conditions Studied

Interventions

  • DEVICE Pulse oximeter

Study Locations (1)

California

  • UCSF Hypoxia Research Laboratory - San Francisco

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2021-03-24
Est. Completion 2022-02-15
Nihon Kohden

14 total trials

What the finished NCT04814342 record still lists

NCT04814342 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Pulse oximeter is the first listed.

NCT04814342 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04814342 about?

NCT04814342 is a clinical study titled "Accuracy of Pulse Oximeters With Profound Hypoxia During Motion". The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients during controlled motion.

What is the current status of trial NCT04814342?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2021-03-24. Estimated completion is 2022-02-15.

What conditions does trial NCT04814342 study?

This clinical trial studies the following conditions: Hypoxia.

What interventions are being tested in trial NCT04814342?

The interventions under investigation include: Pulse oximeter (DEVICE).

Who is sponsoring clinical trial NCT04814342?

This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04814342 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04814342's enrollment target sits among peer trials

5 40th of 39 the lowest of 39 other Hypoxia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04814342, the US trial registry maintained by the National Library of Medicine. NCT04814342 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.